CROFounded 2017
Syneos Health
Morrisville, North Carolina, United States
Integrated biopharmaceutical solutions company that bundles CRO clinical trial execution with medical affairs, patient engagement, and commercial/marketing services, distinguishing it from clinical-only CROs.
- Segment
- CRO
- Headquarters
- Morrisville, North Carolina, United States
- Founded
- 2017
- Website
- www.syneoshealth.com
Notable facts
- Formed through the August 1, 2017 merger of INC Research (a CRO founded 1998) and inVentiv Health (a commercial services provider established in 2001); the combined company was renamed Syneos Health effective January 4, 2018.
- Taken private in a deal completed September 30, 2023 by a consortium led by Elliott Investment Management, Patient Square Capital, and Veritas Capital for $43/share (about $4.46 billion), ending its run on Nasdaq.
- Reported 2022 revenue of $5.39 billion with clinical services contributing about 75% and commercial services about 25%; employed roughly 28,000 people across 110 countries.
Sourcing guides
Sources. This profile is compiled from public reference data, WebSearch-verified against source 1 · source 2. Data as of 2026-07-14. See methodology.
Sourcing a vendor in this segment today? We connect clinical operations, regulatory, and procurement teams with qualified cro vendors.
Request vendors